2nd Quarter - Report — NATIONAL KIDNEY FOUNDATION for NATIONAL KIDNEY FOUNDATION (2019)

Firm

NATIONAL KIDNEY FOUNDATION

Client

NATIONAL KIDNEY FOUNDATION

Income

—

Expenses

$100,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Early detection and management of Chronic Kidney Disease, including Alternative Payment Model Increased utilization of home dialysis Extension of Medicare coverage of immunosuppressive drugs for kidney transplant recipients Increased use of Kidney Discards for transplantation Access of medications under Medicare Part D Protected Classes

Lobbyist	Covered position, as disclosed
ANDREW W. FULLERTON	—
TONYA SAFFER	—
TROY ZIMMERMAN	—

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE; Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Natl Institutes of Health (NIH)

Budget/Appropriations BUD

FY 2020 Appropriations for the Department of Health and Human Services (NIH, CDC, HRSA); Food and Drug Administration; Indian Health Service, Veterans Affairs, and Department of Defense

Lobbyist	Covered position, as disclosed
TONYA SAFFER	—
TROY ZIMMERMAN	—

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); Health Resources & Services Administration (HRSA); SENATE; Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Health Issues HCR

Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); the National Living Donor Assistance Center; increased utilization of Kidney Discards Early detection and management of Chronic Kidney Disease Department of Health and Human Services Million Hearts initiative Department of Health and Human Services KidneyX initiative Prescription Drug Pricing and Access Healthy People 2030 Management of the Patient Protection and Affordable Care Act Reauthorization of the Patient-Centered Outcomes Research Institute Repeal and Replacement of the Affordable Care Act

Lobbyist	Covered position, as disclosed
ANDREW W. FULLERTON	—
TONYA SAFFER	—
TROY ZIMMERMAN	—

Contacted: Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Bills named: S. 511 (116th), H.R. 1224 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.